Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
deals
3
×
ipo
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
sanofi
3
×
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
bio
drug
ipo
medicines
roundup
acquisitions
alzheimer’s
announced
cancer
ceo
collabs
companies
covid
daniel
deal
despite
different
fail
family
gene
gilead
gilead’s
hardest
help
hit
hottest
hunters
increases
introduce
latest
month
o’day
pharmaceutical
plan
plans
prescription
price
prices
proteins
raise
Language
unset
Current search:
sanofi
×
deals
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More